Journal article
Neuroinflammation as molecular landscape of post-operative delirium revealed by live human brain multi-omics profiling
Molecular psychiatry
08/05/2026
DOI: 10.1038/s41380-026-03804-z
PMID: 42557393
Abstract
Post-operative delirium (POD) is a serious complication of surgery particularly in older adults, characterized by acute disturbances in consciousness and cognition and associated with increased mortality and long-term cognitive impairment. Despite its clinical relevance, the underlying pathophysiology remains poorly understood. To address this, we performed multi-omics profiling of live brain tissue from patients undergoing neurosurgery. Single-nucleus RNA sequencing revealed POD-specific transcriptional alterations in glial cells, especially microglia, characterized by enhanced neuroinflammatory signatures. Astrocytes also exhibited changes in synaptic and migratory pathways. Upstream analysis implicated external cytokines as potential drivers of glial responses, while downstream analysis linked POD to encephalitis and dementia. DNA methylation profiling identified immune-related epigenetic alterations, suggesting a regulatory role in POD-associated neuroinflammation. Integration of bulk methylation and cell type-specific transcriptomic data suggested that epigenetic changes may influence gene expression during POD pathogenesis. These findings provide the convincing evidence of neuroinflammation and glial involvement as the pathophysiological mechanism of POD based on the first multi-omics analysis using patient brain tissue.
Details
- Title: Subtitle
- Neuroinflammation as molecular landscape of post-operative delirium revealed by live human brain multi-omics profiling
- Creators
- Takaya Ishii - Sumitomo Dainippon Pharma (Japan)Tao Wang - Stanford UniversityKazuki Shibata - Sumitomo Dainippon Pharma (Japan)Shota Nishitani - Stanford UniversityTakehiko Yamanashi - Tottori UniversityNadia E Wahba - University of IowaTomoteru Seki - Tokyo Medical UniversityKaitlyn J Thompson - University of IowaKyosuke Yamanishi - Stanford UniversityTsuyoshi Nishiguchi - Stanford UniversityAkiyoshi Shimura - Tokyo Medical UniversityBun Aoyama - National Hospital Organization Kochi National HospitalNipun Gorantla - Stanford UniversityNathan J Phuong - Stanford UniversityHieu D Nguyen - Stanford UniversityTherese A Santiago - Stanford UniversityYoshitaka Nishizawa - Osaka University of Pharmaceutical SciencesTakaaki Nagao - Toho UniversityMathew A Howard III - University of Iowa, Iowa Neuroscience InstituteHiroto Kawasaki - University of IowaKyosuke Hino - Sumitomo Dainippon Pharma (Japan)Atsushi Ikeda - Sumitomo Dainippon Pharma (Japan)Michael P Snyder - Stanford UniversityGen Shinozaki - University of Iowa
- Resource Type
- Journal article
- Publication Details
- Molecular psychiatry
- DOI
- 10.1038/s41380-026-03804-z
- PMID
- 42557393
- NLM abbreviation
- Mol Psychiatry
- ISSN
- 1476-5578
- eISSN
- 1476-5578
- Publisher
- Springer Nature; LONDON
- Grant note
- R01 MH119165 / U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (NIMH) AG084710 / U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (NIMH)
- Language
- English
- Electronic publication date
- 08/05/2026
- Academic Unit
- Neurology; Psychiatry; Iowa Neuroscience Institute; Neurosurgery; Otolaryngology
- Record Identifier
- 9985217066302771
Metrics
4 Record Views